Other tuberculosis of nervous system
ICD-10 A17.8 is a billable code used to indicate a diagnosis of other tuberculosis of nervous system.
Other tuberculosis of the nervous system refers to forms of tuberculosis that affect the central or peripheral nervous system, excluding the more common forms such as tuberculous meningitis or spinal tuberculosis. This condition can manifest as tuberculomas, which are localized lesions in the brain or spinal cord, or as disseminated tuberculosis affecting the nervous system. Symptoms may include neurological deficits, seizures, headaches, and altered mental status. Diagnosis typically involves imaging studies such as MRI or CT scans, along with microbiological tests including sputum cultures and PCR testing for Mycobacterium tuberculosis. Treatment usually involves a prolonged course of antitubercular medications, often requiring monitoring for drug resistance and side effects. Public health implications are significant, as tuberculosis is a communicable disease, necessitating contact tracing and isolation procedures for active cases to prevent transmission. Drug resistance is a growing concern, making adherence to treatment protocols critical.
Detailed patient history, including exposure history and previous tuberculosis infections.
Patients presenting with neurological symptoms and a history of tuberculosis.
Need for thorough documentation of treatment adherence and monitoring for drug resistance.
Neurological examination findings, imaging results, and differential diagnoses.
Patients with seizures or cognitive changes who have a history of tuberculosis.
Differentiating symptoms from other neurological conditions and ensuring comprehensive imaging documentation.
Used to evaluate for tuberculomas or other lesions in the brain.
Indication for the scan and findings must be documented.
Neurology and Infectious Disease specialists should ensure imaging correlates with clinical findings.
Common symptoms include seizures, headaches, cognitive changes, and focal neurological deficits, which may vary based on the specific area of the nervous system affected.
Diagnosis typically involves imaging studies such as MRI or CT scans, along with microbiological tests like sputum cultures or PCR for Mycobacterium tuberculosis.
Treatment usually involves a combination of antitubercular medications over an extended period, with careful monitoring for drug resistance and side effects.
Public health measures include contact tracing, isolation of active cases, and monitoring for drug resistance to prevent transmission.
